Records containing: Pseudoxanthoma Elasticum
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Role of Purinergic Compounds in the Vascular Pathology of Pseudoxanthoma Elasticum
-
CLINICAL_TRIALS study record update · 2026-04-06Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE) by the PXE Reference Center at the CHU in Angers, France, Thanks to the Implementation of Alternating Pathways, Adapted to Age and Symptomatology, and Including Teleconsultations
-
CLINICAL_TRIALS study record update · 2026-03-24The ENERGY Study: An Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Infants With Ectonucleotide Pyrophosphatase/ Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency
-
CLINICAL_TRIALS study record update · 2025-12-08CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum
-
CLINICAL_TRIALS study record update · 2025-07-02Natural History and Structural Consequences of a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum (PXE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-22Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
-
CLINICAL_TRIALS study record update · 2025-02-05A Phase 1/2, Open-Label, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 Followed by an Open-Label Long-Term Extension Period in Adults With ABCC6 Deficiency Manifesting as Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2024-12-31A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
-
CLINICAL_TRIALS study record update · 2024-11-29The ADAPT Study: An Open-label, Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
-
CLINICAL_TRIALS study record update · 2024-05-17Efficacy of PyROphosPHate Supplementation to Fight ECtopIc Calcification in PseudoXanthoma Elasticum - PROPHECI-PPI Study
-
CLINICAL_TRIALS study record update · 2023-04-27The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
-
CLINICAL_TRIALS study record update · 2023-02-13Employment Retention Issues for Patient With Pseudoxanthoma Elasticum
-
CLINICAL_TRIALS study record update · 2022-09-06An Evaluation of Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings
-
CLINICAL_TRIALS study record update · 2021-04-22Oral Disodiumpyrophosphate (Na2H2PPi) Absorption in Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2019-12-17Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2019-05-07Intravitreal Aflibercept (Eylea) for Therapy of Choroidal Neovascularization (CNV) and Fibrovascular Proliferation (FVP) in Patients With Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2019-04-25Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2019-02-04Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)
-
CLINICAL_TRIALS study record update · 2018-11-29The Natural History of Generalized Arterial Calcification of Infancy (GACI) With or Without Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2) or Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2018-06-28Glucidic Metabolism, Ossification and Arterial Calcification During PseudoXanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2018-06-20Characterization of Patients With Pseudoxanthoma Elasticum
-
CLINICAL_TRIALS study record update · 2017-12-06Biological Collection of Renal Cells for the Functional Study of the ABCC6 Transporter on iPS-derived Hepatocytes and Renal Cells
-
CLINICAL_TRIALS study record update · 2012-11-21Arterial Wall Calcium Load and Preferential Sites in Pseudoxanthoma Elasticum Versus Type 2 Diabetes and Chronic Kidney Disease.
-
CLINICAL_TRIALS study record update · 2012-11-15Functional and Structural Characterization of the Peripheral Arteriopathy in Pseudoxanthoma Elasticum (PXE)
-
CLINICAL_TRIALS study record update · 2012-10-25Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy With Intravitreal Injection of Lucentis (Ranibizumab Injection)